Georg-Speyer-Haus. Foto: Andreas Reeg, Tel: +40-171-5449247, andreas.reeg@t-online.de, www.andreasreeg.de
Research
Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com

Müge Bozlar

Müge received her Bachelor’s degree from the Department of Molecular Biology and Genetics at İhsan Doğramacı Bilkent University (Turkey) in 2019. She started her Master’s degree under the supervision of Asst. Prof. Bahar Değirmenci at İhsan Doğramacı Bilkent University. During her Master’s thesis, Müge mainly focused on the characterization of fibrogenic cells and the identification… [mehr]

Solidarity with scientists from Ukraine

#ScienceForUkraine – GSH supports initiative for scientists from Ukraine | Frankfurt am Main, March 08, 2022 – The Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy would be glad to host students as well as researchers (internships, bachelor and master theses, PhD, postdoctoral fellows, and associates) in fields of Life and Natural Sciences. We can… [mehr]

New insights in rectal carcinoma therapy

Inflammatory connective tissue cells decrease response to radiochemotherapy | Frankfurt am Main, February 03, 2022 – Within the framework of the LOEWE Centre Frankfurt Cancer Institute (FCI), the group of Prof. Dr. Florian Greten from Georg-Speyer-Haus in cooperation with Prof. Dr. Claus Rödel and Prof. Dr. Dr. Emmanouil Fokas from the Department of Radiotherapy and… [mehr]

Alexander Schäffer

Alexander received his bachelor’s degree in biology from the Hamburg University with specialization in genetics and immunology. He then went on to study molecular medicine at the Goethe University Frankfurt am Main and gained research experience in the group of Lisa Westerberg at the Karolinska Institute in Stockholm (Sweden) where he worked on immunodeficiencies linked… [mehr]

Prof. Dr. Florian Greten

The notion that chronic inflammatory diseases are associated with an elevated risk of tumorigenesis and Rudolf Virchow’s findings in the late 19th century when he described the high frequency of leucocytes in tumor areas led the basis for genetic studies specifically examining the links between inflammation and cancer that had initially…[more]

Dr. Henner Farin

3D organoid culture system Our group studies cell signaling in intestinal stem cells and colorectal cancer (CRC), which is the third leading cause of death from cancer among adults. As a model for the healthy and transformed epithelium we use stem cell-derived ‘organoids’: This 3D culture system allows formation of epithelial…[more]

Postgraduates

"Never stopping to ask questions is crucial." - Albert Einstein PostDocs PhD Students Technicians Animal Caretaker Administration Internships Doctoral Researcher Position in Tumor Biology focusing on Tumor Microenvironment (m/f/d) The Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus in Frankfurt am Main is an academic non-profit research institute supported by the Federal Ministry of Health… [mehr]

Research

Annual Report 2023 Annual Report 2022 Annual Report 2021 Annual Report 2020 Annual Report 2019 Our research In Western countries, one in two men and one in three women will develop a tumor disease in the course of their lives. In Germany, too, the number of people diagnosed with cancer each year remains alarmingly high.… [mehr]

Beug Foundation Research Award for Dr. Sevenich on metastasis research

This year's 2019 Beug Foundation Metastasis Research Award goes to Dr. Lisa Sevenich for her efforts in studying T-cell responses in brain metastases. "I am very honored by this award. The grant from the Beug Foundation will allow us to study new types of aspects of the complex interactions between tumor cells and immune cells… [mehr]

EMBO Young Investigator Award for Hind Medyouf

Dr. Hind Medyouf awarded with EMBO YIP. Dr. Hind Medyouf, Group Leader at the Institute for Tumor Biology and Experimental Therapy and the Frankfurt Cancer Institute, has been awarded the prestigious European Molecular Biology Organization (EMBO) Young Investigator Programme (YIP) for the year 2018. She joins an active network of more than 100 current and… [mehr]